The institute seminar on Wednesday February 13th will be held by Jostein Dahle, head of the Radiotherapy project group at the Department of Radiation Biology.
The title of his talk is "Alpha‐particle based radioimmunotherapy of cancer"
Time and place: 12:00, Seminar Room, F4, Institute for Cancer Research.
From major journals, first or last author from the Institute for Cancer Research
Ianevski A, Nader K, Driva K, Senkowski W, Bulanova D, Moyano-Galceran L, Ruokoranta T, Kuusanmäki H, Ikonen N, Sergeev P, Vähä-Koskela M, Giri AK, Vähärautio A, Kontro M, Porkka K, Pitkänen E, Heckman CA, Wennerberg K, Aittokallio T(2024) Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones Nat Commun, 15(1), 8579 DOI 10.1038/s41467-024-52980-5, PubMed 39362905
Jin Y, Dunn C, Persiconi I, Sike A, Skorstad G, Beck C, Kyte JA(2024) Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586 Int J Mol Sci, 25(18) DOI 10.3390/ijms251810024, PubMed 39337718
Skingen VE, Salberg UB, Hompland T, Fjeldbo CS, Helgeland H, Frikstad KM, Ragnum HB, Vlatkovic L, Hole KH, Seierstad T, Lyng H(2024) Spatial analysis of microRNA regulation at defined tumor hypoxia levels reveals biological traits of aggressive prostate cancer J Pathol(in press) DOI 10.1002/path.6344, PubMed 39329425